Have a personal or library account? Click to login
The relative bioavailability of two formulations containing 10 mg Dapagliflozin assessed under fasting conditions in a randomized crossover study in healthy Caucasian subjects Cover

The relative bioavailability of two formulations containing 10 mg Dapagliflozin assessed under fasting conditions in a randomized crossover study in healthy Caucasian subjects

Acta Marisiensis - Seria Medica
Volume 66 (2020): Issue 1 (March 2020)
By: Monica Oroian,  Diana Ioana Pop,  Ana-Maria Gheldiu,  Sandeep Bhardwaj,  Adriana Marcovici,  Arshad Khuroo and  Laurian Vlase  
Open Access
|Mar 2020

Metrics

DOI: https://doi.org/10.2478/amma-2020-0006 | Journal eISSN: 2668-7763 | Journal ISSN: 2668-7755
Journal RSS Feed
Language: English
Page range: 30 - 34
Submitted on: Aug 1, 2019
|
Accepted on: Jan 29, 2020
|
Published on: Mar 31, 2020
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
dapagliflozin,
bioequivalence trial,
Caucasian subjects,
fasted state
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other

© 2020 Monica Oroian, Diana Ioana Pop, Ana-Maria Gheldiu, Sandeep Bhardwaj, Adriana Marcovici, Arshad Khuroo, Laurian Vlase, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 66 (2020): Issue 1 (March 2020)